On March 29th, a groundbreaking model tailored exclusively for Type 1 diabetes was unveiled worldwide. This model represents a pivotal advancement stemming from China's national "Four Major Chronic Diseases" initiative, led by Weng Jianping, a distinguished professor at the University of Science and Technology of China and president of Anhui Medical University. iFLYTEK Healthcare partnered with numerous institutions to bring this innovation to life. Leveraging the iFLYTEK Spark Medical Large Model X1, this comprehensive model integrates multimodal data and extensive clinical expertise to create a seamless digital and intelligent healthcare continuum that encompasses screening, classification, treatment, and management. In rigorous testing across 65 core scenarios, its performance surpassed that of GPT-4 and DeepSeek-R1, offering Type 1 diabetes patients a smarter and more precise health management solution.